论文部分内容阅读
目的探讨运用通心络胶囊治疗糖尿病心肌病患者的临床效果。方法将2013年1月至2015年1月到鞍山市中医院治疗的72例糖尿病心肌病病例通过随机对照法均分为两组,对照组36例患者根据常规内科标准用药,包括抗血小板凝集、降血糖、调脂及口服硝酸酯类药物等措施,观察组36例患者施加通心络胶囊口服,连续施治4周后,研究两组患者的临床效果。结果观察组患者实施治疗后的临床总有效率达91.7%(33/36),相比对照组的75.0%(27/36)明显更高,差异有统计学意义(P<0.05)。治疗前,两组患者各项血糖、心功能指标基本接近,差异均无统计学意义(均P>0.05);治疗后,两组各项血糖与心功能指标均出现不同程度的变化,但观察组患者各项平均值相比对照组改善更理想,差异均有统计学意义(均P<0.05)。结论对糖尿病心肌病患者实施通心络胶囊治疗,临床效果更加理想,且能有效调节血糖水平,促进患者心功能的恢复。
Objective To investigate the clinical effect of Tongxinluo Capsule in the treatment of diabetic cardiomyopathy. Methods A total of 72 diabetic cardiomyopathy cases from January 2013 to January 2015 in Anshan Traditional Chinese Medicine Hospital were divided into two groups according to randomized control. Thirty-six patients in the control group were treated according to routine medical standards, including anti-platelet aggregation, Hypoglycemic, lipid-lowering and oral nitrates and other measures, the observation group of 36 patients administered Tongxinluo capsule oral administration of four consecutive weeks after treatment, the clinical efficacy of two groups of patients. Results The total effective rate of the observation group was 91.7% (33/36) after treatment, which was significantly higher than that of the control group (75.0%, 27/36). The difference was statistically significant (P <0.05). Before treatment, the two groups of patients with various blood glucose and cardiac function basically close, the difference was not statistically significant (all P> 0.05); after treatment, the two groups of various indicators of blood glucose and cardiac function have varying degrees of change, but observed Compared with the control group, the mean values of all the groups improved more satisfactorily (all P <0.05). Conclusions Tongxinluo capsule is effective in patients with diabetic cardiomyopathy. The clinical effect is more ideal, and it can effectively regulate blood sugar level and promote the recovery of cardiac function.